The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Attention Disorders

• Publication date

  2014-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/1087054712448252PMID 22740112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

  2012cited by this paper
• Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review

  2011influential reference
• Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.

  2010influential reference
• Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study

  2010cited by this paper
• Duration of effect of oral long-acting stimulant medications for ADHD throughout the day

  2010cited by this paper
• Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study

  2009influential reference
• Emotional Expression in Children Treated With ADHD Medication

  2008influential reference
• Effect of Lisdexamfetamine Dimesylate on Parent-Rated Measures in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis

  2008cited by this paper
• Emotional Expression During Attention-Deficit/Hyperactivity Disorders Treatment: Initial Assessment of Treatment Effects

  2007cited by this paper
• Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

  2007influential reference
• Emotional and Behavioral Difficulties and Impairments in Everyday Functioning Among Children With a History of Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Efficacy and Duration of Effect of Extended-Release Dexmethylphenidate Versus Placebo in Schoolchildren With Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

  2005cited by this paper
• ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.

  2005cited by this paper
• Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2004cited by this paper
• A prospective study of stimulant response in preschool children: insights from ROC analyses.

  2004cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

  2003cited by this paper
• Confirmatory Factor Analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a Clinical Sample

  2002cited by this paper
• ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

  2001cited by this paper
• Mania and ADHD: comorbidity or confusion.

  1998cited by this paper
• The Revised Conners' Parent Rating Scale (CPRS-R): Factor Structure, Reliability, and Criterion Validity

  1998cited by this paper
• Manic symptoms in psychiatrically hospitalized children--what do they mean?

  1998cited by this paper
• Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• Placebo-controlled evaluation of Ritalin side effects.

  1993cited by this paper
• Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

  1991cited by this paper

• Clinical and cost-effectiveness of technologies for the assessment of attention deficit hyperactivity disorder: a systematic review and economic model.

  2025cites this paper
• Diagnostic persistence, autistic traits, and resilience in youth and adolescents with attention deficit hyperactivity disorder.

  2025cites this paper
• A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials

  2024cites this paper
• Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)

  2023cites this paper
• Examining bidirectional associations between sleep and behavior among children with attention‐deficit/hyperactivity disorder

  2023cites this paper
• History of Childhood/Adolescence Referral to Speciality Care or Treatment in Adult Patients with Attention-Deficit/Hyperactivity Disorder: Mutual Relations with Clinical Presentation, Psychiatric Comorbidity and Emotional Dysregulation

  2023cites this paper
• Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity Disorder.

  2022cites this paper
• The Impact of Persistent Irritability on the Medication Treatment of Paediatric Attention Deficit Hyperactivity Disorder

  2021cites this paper
• Psychopharmacology of Treating Explosive Behavior.

  2021cites this paper
• Efficacy of psychosocial interventions for children with ADHD and emotion dysregulation: a systematic review.

  2020cites this paper
• Adverse effects of stimulant medications in children and adolescents: focus on drug abuse

  2019cites this paper
• Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention.

  2019cites this paper
• The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials

  2018influential citation
• Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity

  2018cites this paper
• The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD

  2018cites this paper
• Effectiveness and adverse effects of methylphenidate treatment in children diagnosed with disruptive mood dysregulation disorder and attention-deficit hyperactivity disorder: a preliminary report

  2017cites this paper
• ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years

  2017cites this paper
• Irritability and Anxiety Severity Among Youth With Anxiety

  2017cites this paper
• Irritability and Severity of Anxious Symptomatology Among Youth With Anxiety Disorders.

  2016cites this paper
• Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects.

  2016cites this paper
• Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials

  2015cites this paper
• Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA)

  2015cites this paper
• Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes

  2015cites this paper
• Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy

  2015cites this paper
• Stimulants, cognition and ADHD

  2015cites this paper
• Emotion dysregulation in attention deficit hyperactivity disorder.

  2014cites this paper
• Trouble déficit d’attention/hyperactivité (TDA/H) et émotions : de la labilité émotionnelle au trouble bipolaire

  2014cites this paper
• Abnormal amygdala functional connectivity associated with emotional lability in children with attention-deficit/hyperactivity disorder.

  2014cites this paper
• Emotional lability: the discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults.

  2014cites this paper
• The use of stimulant medications for non-core aspects of ADHD and in other disorders.

  2014cites this paper
• Using Stimulants to Treat ADHD-Related Emotional Lability

  2014cites this paper
• Managing the Risks of ADHD Treatments

  2014cites this paper
• Reviews and Overviews Mechanisms of Psychiatric Illness Emotion Dysregulation in Attention De fi cit Hyperactivity Disorder

  2014cites this paper
• Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder with Emotional Control Impairments

  2013cites this paper